Patent · US Active

Assay for detecting human papilloma virus (HPV)

US11384398B2 · kind B2 · utility

1Cited by

6References

9Claims

0Family size

Assignee

Abbott Molecular Inc. · US

Inventors

Wesley Grimm · Des Plaines, US
Joshua Kostera · Des Plaines, US
Robert Hillman · Poway, US
Hong Wang · Nanhu, CN
Ning Tang · Libertyville, US
Shihai Huang · Des Plaines, US
Klara Abravaya · Kenilworth, US

Key dates

Filing date	Dec 18, 2019
Grant date	Jul 12, 2022
Priority date	—
Expiry date	Jul 27, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/025
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.